Biocon Pays $3.3bn For Viatris Biosimilars Business

‘Transformational’ Deal Offers Biocon Portfolio, Pipeline And Global Presence

 
• By Dave Wallace
  
Jigsaw pieces sunset
The deal combines Biocon Biologics with Viatris biosimilars • Source: rangizzz / Alamy Stock Photo

More from Deals

More from Business